SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about analyst meeting

24 Jan 2018 Evaluate

Pursuant to Regulation 30(6) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that few Analysts/ Individual and Institutional Investor/ Stock Broker would be visiting Bhiwadi Plant and Meeting with the Senior Management of the Company on Saturday the 27th day of January, 2018.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

237.75 -0.55 (-0.23%)
24-Jul-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1958.55
Dr. Reddys Labs. 1145.50
Cipla 1430.90
Lupin 2381.50
Zydus Lifesciences 1116.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: